Astera Labs, Inc. $ALAB Position Cut by Timothy G. Youngquist 2020 Irrevocable Trust

Timothy G. Youngquist 2020 Irrevocable Trust reduced its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 59.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,395 shares of the company’s stock after selling 7,923 shares during the quarter. Astera Labs accounts for 0.5% of Timothy G. Youngquist 2020 Irrevocable Trust’s portfolio, making the stock its 23rd largest position. Timothy G. Youngquist 2020 Irrevocable Trust’s holdings in Astera Labs were worth $2,606,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Eurizon Capital SGR S.p.A. acquired a new position in Astera Labs in the fourth quarter worth approximately $18,708,000. Swedbank AB lifted its position in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after acquiring an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of Astera Labs during the 4th quarter valued at $499,000. Revere Asset Management Inc bought a new stake in shares of Astera Labs during the 4th quarter worth $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new stake in shares of Astera Labs during the 4th quarter worth $10,299,000. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total value of $3,276,963.90. Following the completion of the sale, the director owned 5,292 shares of the company’s stock, valued at approximately $1,928,140.20. The trade was a 62.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 631,979 shares of company stock worth $215,479,247. Company insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent analyst reports. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Bank of America increased their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Citigroup reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. JPMorgan Chase & Co. boosted their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Finally, Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $303.44 on Wednesday. The business has a 50 day simple moving average of $356.72 and a 200 day simple moving average of $242.75. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The stock has a market cap of $52.64 billion, a price-to-earnings ratio of 150.22 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.